Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard Essner, M.D.
Saint John's Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
63 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Newcastle Melanoma Unit
Newcastle, New South Wales, Australia
- Melanoma Institute Australia
Sydney, New South Wales, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Alfred Hospital
East Hawthorn, Victoria, Australia
- Peter Maccallum Cancer Centre
East Melbourne, Victoria, Australia
- Tom Baker Cancer Center
Calgary, Alberta, Canada
- Sunnybrook Health Sciences Center
Toronto, Ontario, Canada
- Helsinki Unversity Hospital
Helsinki, Finland
- U. Hosp. Schleswig-Holstein/campus Lubeck
Lübeck, Germany
- City Hospital of Nurnberg
Nuremberg, Germany
- University of Wurzburg
Würzburg, Germany
- Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
- Istituto Europeo Di Oncologia
Milan, Italy
- Istituto Nazionale Dei Tumori Napoli
Naples, Italy
- Istituto Oncologico Veneto - University of Padova
Padova, Italy
- Padua University - Clinica Chirurgica Ii
Padua, Italy
- Netherlands Cancer Institute
Amsterdam, Netherlands
- Universitair Medisch Centrum Groningen
Groningen, Netherlands
- Hospital Clinic Barcelona
Barcelona, Spain
- Swedish Melanoma Study Group
Lund, Sweden
- Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
- University of Zurich
Zurich, Switzerland
- Norfolk and Norwich University Hospital
Norfolk, Norwich, United Kingdom
- Saint Thomas'S Hospital
London, United Kingdom
- Sharp Hospital
San Diego, California, United States
- John Wayne Cancer Institute
Santa Monica, California, United States
- Memorial Hospital - Colorado Springs
Colorado Springs, Colorado, United States
- Lakeland Regional Cancer Center
Lakeland, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- Rush University
Chicago, Illinois, United States
- University of Louisville
Louisville, Kentucky, United States
- Johns Hopkins Medical Institute
Baltimore, Maryland, United States
- Mercy Medical Center
Baltimore, Maryland, United States
- University of Michigan
Ann Arbor, Michigan, United States
- St. Louis University
St Louis, Missouri, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Buffalo General Hospital
Buffalo, New York, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Feinstein Institute for Medical Research
Great Neck, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2004
- Primary completion
- 30 Sept 2019
- Completion
- 30 Sept 2019
- Last update posted
- 13 May 2022
- Registered enrollment
- 1,939
- Registry id
- NCT00297895
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.